Results 91 to 100 of about 39,925 (149)

Prevalence and specificities of red cell alloantibodies among blood recipients in the Malaysian state of Kelantan

Asian Journal of Transfusion Science, 2011
Background: Red blood cell (RBC) alloantibodies may be formed following exposure to RBC antigens. In most cases, the alloimmunization develops during pregnancy or from previous blood transfusions.
Al-Joudi Fawwaz, Ali Anuar, Ramli Majdan, Ahmed Suhair, Ismail Mohd   +4 more
doaj  

Clinical Study The Association of CD81 Polymorphisms with Alloimmunization in Sickle Cell Disease

, 2020
The goal of the present work was to identify the candidate genetic markers predictive of alloimmunization in sickle cell disease (SCD). Red blood cell (RBC) transfusion is indicated for acute treatment, prevention, and abrogation of some complications of
Zohreh Tatari-Calderone, François Lionnet, Stanislav Vukmanovic, Jacqueline Lasserre, Gama P Le Bouder, Naomi L C Luban, Ramita Dewan, Rajagopal Krishnamoorthy, Jacqueline Maury, Robert Girot, Ryad Tamouza   +10 more
core  

Suppression of RBC alloimmunization and regulation of CD4⁺T cell dependence by C3 is not due to genetic confounders in mice. [PDF]

Transfusion
Jash A, Hay A, Zimring JC.
europepmc   +1 more source

Evaluation of post-transfusion RBC alloimmunization in dogs using a gel-column crossmatch with and without anti-canine globulin enhancement. [PDF]

J Vet Diagn Invest
Thomas-Hollands A, Hess RS, Weinstein NM, Fromm S, Chappini NA, Marryott K, Callan MB.   +6 more
europepmc   +1 more source

Prevalence of Alloimmunization Among Patients With Transfusion-Dependent Thalassemia and Sickle Cell Disease in Salmaniya Medical Complex, Bahrain. [PDF]

Cureus
Altooq J, Sultan Z, Harb Z, Abdulla F, AlOmran M, Almeshal S.   +5 more
europepmc   +1 more source

Antibody-Dependent and Antibody-Independent Hemolysis in Sickle Cell Disease. [PDF]

Antibodies (Basel)
Glover RT, Maitta RW.
europepmc   +1 more source

Expanding the spectrum of post-HSCT hemolysis: from passenger lymphocyte syndrome to host- and graft-associated alloimmune hemolytic anemia. [PDF]

Blood Res
Jekarl DW, Lee J, Cha Y, Han JH, Cho SH, Lim J, Kim Y.   +6 more
europepmc   +1 more source

Engineering the Universal Donor: CRISPR-Mediated Blood Group Antigen Deletion and the Path Toward Truly Universal Red Blood Cells-A Narrative Review. [PDF]

Diagnostics (Basel)
Altayar MA.
europepmc   +1 more source

Targeting erythroid cell-derived asparagine inhibits alloimmunization in sickle cell disease. [PDF]

Blood Adv
Dou K, Su S, Bao W, Liu Y, Jin Q, Manwani D, Murakhovskaya I, Campbell-Lee S, Shi P, Lobo C, An X, Yazdanbakhsh K, Zhong H.   +12 more
europepmc   +1 more source

Red blood cell transfusion survival in sickle cell disease is reduced by donor characteristics and recipient spleen activity. [PDF]

Blood Adv
Yee MEM, Zerra PE, Francis RO, Easley KA, Lough CM, McCoy JW, Naseh Z, Delvadia BB, Parikh AK, Butler HE, Stowell SR, Joiner CH, Josephson CD, Roback JD, Fasano RM.   +14 more
europepmc   +1 more source